BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy
Public ClinicalTrials.gov record NCT01873404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Using a Bayesian Adaptive Design to Assess the Efficacy, Safety, Tolerability, and Serum Exposure of Multiple Doses of BG00010 (Neublastin) in Subjects With Painful Lumbar Radiculopathy
Study identification
- NCT ID
- NCT01873404
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 183 participants
Conditions and interventions
Conditions
Interventions
- BG00010 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2013
- Primary completion
- Feb 28, 2015
- Completion
- Feb 28, 2015
- Last update posted
- Sep 9, 2015
2013 – 2015
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85018 | — |
| Research Site | Fresno | California | 93710 | — |
| Research Site | Lomita | California | 90717 | — |
| Research Site | Long Beach | California | 90806 | — |
| Research Site | Pasadena | California | 91105 | — |
| Research Site | Fort Lauderdale | Florida | 33312 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Sarasota | Florida | 34232 | — |
| Research Site | St. Petersburg | Florida | 33713 | — |
| Research Site | Sunrise | Florida | 33351 | — |
| Research Site | Tampa | Florida | 33606 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Columbus | Georgia | 31904 | — |
| Research Site | Savannah | Georgia | 31406 | — |
| Research Site | Bloomington | Illinois | 61701 | — |
| Research Site | Chicago | Illinois | 60657 | — |
| Research Site | Evansville | Indiana | 47714 | — |
| Research Site | Overland Park | Kansas | 66210 | — |
| Research Site | Brockton | Massachusetts | 02301 | — |
| Research Site | Lincoln | Nebraska | 68521 | — |
| Research Site | Raleigh | North Carolina | 27612 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | San Antonio | Texas | 78731 | — |
| Research Site | Salt Lake City | Utah | 84106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01873404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2015 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01873404 live on ClinicalTrials.gov.